The regional laboratory will use the Concentriq platform to expand diagnostic services and streamline clinical workflows across its network.

Pathologie Friesland, a regional pathology laboratory in the Netherlands, is implementing Proscia’s Concentriq platform to anchor its digital pathology network and prepare for future growth. The transition is intended to help the laboratory expand its diagnostic reach while establishing a foundation for artificial intelligence (AI) applications.

Serving the Dutch province of Friesland, the laboratory reviews hundreds of thousands of images annually for hospitals, general practitioners, and private clinics. As demand for services evolves, the organization is centering its operations on a platform designed to onboard new sites and streamline clinical operations.

“While we have been largely digital for years, this is about what comes next,” says Gijsbert Zijlstra, ceo at Pathologie Friesland, in a release. “Concentriq AP-Dx gives us a flexible foundation for growth. With the platform, our expanding team can deliver more diagnoses faster for the providers and patients who rely on us.”

The laboratory selected the Concentriq AP-Dx platform following what it described as a “rigorous” evaluation. The system was named Global 2026 Best in KLAS for Digital Pathology in Europe, recognized for its interoperability and scalability. Pathologie Friesland will deploy the platform on Amazon Web Services to ensure reliability and data security.

“An important reason we chose Concentriq AP-Dx is the openness of the platform and the flexibility it offers to suit our specific needs and workflow,” says Marcel Dijkstra, pathologist at Pathologie Friesland, in a release. “Concentriq AP-Dx gives us the freedom to build in a way that fits our practice and supports how we want to grow as a digital pathology network.”

The platform serves as a hub for more than 130 AI applications, allowing the laboratory to integrate automated tools into its daily practice. Pathologie Friesland plans to begin its AI implementation by using a quality control application as an initial step to monitor diagnostic standards.

“AI will play a growing role in the future of pathology,” says Marjolein Coster-Heerema, pathologist at Pathologie Friesland, in a release. “Concentriq AP-Dx is designed with AI built into the platform in a way that fits naturally into our daily practice. This will allow us to focus more on the work that matters most in patient care.”

According to the company, the platform is designed to provide the performance required for large-scale digital pathology networks.

“Pathologie Friesland is showing how laboratories can make a bigger impact and expand access to diagnoses while staying true to the standards their communities depend on,” says David West, ceo of Proscia, in a release. “Its team thinks deeply about the people behind every case, from the pathologists using technology to the patients waiting for answers.”

ID 69655732 © Lucadp | Dreamstime.com

Related Reading: